US 10036751
Method of evaluating glioblastoma multiforme patient applicable to immunotherapy treatment based on dendritic cell tumor vaccines and method of prognosticating survival rate in glioblastoma mulztiforme patient after treatment
granted A61PA61P35/00
Quick answer
US patent 10036751 (Method of evaluating glioblastoma multiforme patient applicable to immunotherapy treatment based on dendritic cell tumor vaccines and method of prognosticating survival rate in glioblastoma mulztiforme patient after treatment) held by China Medical University Hospital expires Mon Jul 26 2038 00:00:00 GMT+0000 (Coordinated Universal Time). Status: granted.
Key facts
- Applicant
- China Medical University Hospital
- Grant date
- Tue Jul 31 2018 00:00:00 GMT+0000 (Coordinated Universal Time)
- Expiration
- Mon Jul 26 2038 00:00:00 GMT+0000 (Coordinated Universal Time)
- Claims
- 5
- CPC classes
- A61P, A61P35/00